Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 51 citing articles:

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 131
Recent progress of metal‐based nanomaterials with anti‐tumor biological effects for enhanced cancer therapy
Huali Lei, Zifan Pei, Chenyu Jiang, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 94
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 24
Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential
Jiachen Li, Shiqi Wang, Flavia Fontana, et al.
Bioactive Materials (2022) Vol. 23, pp. 471-507
Open Access | Times Cited: 67
Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison
Xinyi Zhang, Hengqing Cui, Wenjun Zhang, et al.
Bioactive Materials (2022) Vol. 22, pp. 491-517
Open Access | Times Cited: 45
Enhanced Immunogenic Cell Death and Antigen Presentation via Engineered Bifidobacterium bifidum to Boost Chemo-immunotherapy
Tingting He, Lu Wang, Shuangquan Gou, et al.
ACS Nano (2023) Vol. 17, Iss. 11, pp. 9953-9971
Closed Access | Times Cited: 39
Colorectal cancer vaccines: The current scenario and future prospects
Wenqing Jia, Tao Zhang, Haiyan Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
A Purposefully Designed pH/GSH‐Responsive MnFe‐Based Metal‐Organic Frameworks as Cascade Nanoreactor for Enhanced Chemo‐Chemodynamic‐Starvation Synergistic Therapy
Wei Jun Chen, Dhanu Gupta, Meiyang Yang, et al.
Small (2023) Vol. 19, Iss. 50
Closed Access | Times Cited: 34
Porous Silicon Nanocarriers Boost the Immunomodulation of Mitochondria-Targeted Bovine Serum Albumins on Macrophage Polarization
Jialiang Li, Jiqiang Fan, Yan Gao, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 1036-1053
Open Access | Times Cited: 26
Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Qiuyan Guo, Shengmei Wang, Rubing Xu, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10608-10637
Open Access | Times Cited: 15
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 10
Multifaceted therapeutic applications of biomimetic nanovaccines
Dev Chheda, Sukhen Shete, Tanisha Tanisha, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 6, pp. 103991-103991
Open Access | Times Cited: 8
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Meihua Yu, Wei Yang, Wenwen Yue, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 37
Smart Nanoparticle‐Based Platforms for Regulating Tumor Microenvironment and Cancer Immunotherapy
Ruoyu Cheng, Hélder A. Santos
Advanced Healthcare Materials (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 37
Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy
Yanni Ge, Jiaojiao Zhang, Kai Jin, et al.
Acta Biomaterialia (2023) Vol. 167, pp. 551-563
Open Access | Times Cited: 19
Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
Shuodan Huang, Yan Gao, Huiying Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 5
Open Access | Times Cited: 19
Multifunctional theranostic nanomedicines for cancer treatment: Recent progress and challenges
Laxmanan Karthikeyan, Shankar Sobhana, Vellingiri Yasothamani, et al.
Biomedical Engineering Advances (2023) Vol. 5, pp. 100082-100082
Open Access | Times Cited: 18
Rough Nanovaccines Boost Antitumor Immunity Through the Enhancement of Vaccination Cascade and Immunogenic Cell Death Induction
Xiaoyi Zhao, Jiatong Zhang, Beibei Chen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 17
Dual-Oxygenation/Dual-Fenton Synergistic Photothermal/Chemodynamic/Starvation Therapy for Tumor Treatment
Hongmei Kang, Lamei Chen, Qin Li, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 12, pp. 15129-15139
Closed Access | Times Cited: 17
Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor
Ya‐Jia Xie, Wen-Qian Liu, Dan Li, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 394-394
Open Access | Times Cited: 14
Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection
Feng Xu, Ye Yuan, Ying Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114117-114117
Open Access | Times Cited: 21
Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications
Assaf Zinger
Journal of Controlled Release (2023) Vol. 358, pp. 591-600
Closed Access | Times Cited: 11
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top